Annual EBIT
-$241.60M$64.69M-36.57%
Summary
- Current Value
- As of today, NAMS annual EBIT is -$241.60M, down -36.57% on
- Historical Performance
- NAMS annual EBIT is down -483.94% over the past 3 years, and down -3534.22% over the past 5 years
- All-Time High Comparison
- NAMS annual EBIT is currently -3534.22% below its historical high of -$6.65M set on
- 3-Year Low Comparison
- NAMS annual EBIT is at its 3-year low
- Sector Comparison
- NAMS annual EBIT is higher than 6.77% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$241.60M | -36.6% | -483.9% | -3534.2% | -3534.2% | |
| Quarterly EBIT | -$55.14M | -126.3% | -2304.2% | -10000.0% | -10000.0% | |
| TTM EBIT | -$202.93M | -54.3% | -3891.9% | -10000.0% | -10000.0% | |
| Price | $35.81 | +40.1% | +211.1% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $45.56M | +223.4% | +100.0% | +100.0% | +100.0% | |
| Annual EPS | -$2.56 | -18.9% | -1187.7% | -10000.0% | -10000.0% | |
| Annual EBITDA | -$241.49M | -36.5% | -483.7% | -3533.2% | -3533.2% | |
| Annual Net Income | -$241.60M | -36.5% | -5881.9% | -10000.0% | -10000.0% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$22.35M | N/A | -981.1% |
| 5Y | -$6.65M | N/A | -3534.2% |
| All | -$6.65M | -3534.2% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$241.60M | at low | |
| 5Y | -$241.60M | at low | |
| All | -$241.60M | at low |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$241.60M | -36.6% | |
| -$176.91M | -691.6% | |
| -$22.35M | +46.0% |
| Year | Value | Change |
|---|---|---|
| -$41.37M | -522.4% | |
| -$6.65M | - |
FAQ
What is the current annual EBIT of NAMS?
As of today, NAMS annual EBIT is -$241.60M
What is 1-year change in NAMS annual EBIT?
NAMS annual EBIT is down -36.57% year-over-year
What is 3-year change in NAMS annual EBIT?
NAMS annual EBIT is down -483.94% over the past 3 years
How far is NAMS annual EBIT from its all-time high?
NAMS annual EBIT is currently -3534.22% below its historical high of -$6.65M set on December 1, 2020
How does NAMS annual EBIT rank versus sector peers?
NAMS annual EBIT is higher than 6.77% of companies in Healthcare sector
When is NAMS next annual earnings release?
The next annual earnings release for NAMS is on
Quarterly EBIT
-$55.14M$19.51M-54.74%
Summary
- Current Value
- As of today, NAMS quarterly EBIT is -$55.14M, down -54.74% on
- Historical Performance
- NAMS quarterly EBIT is down -126.33% year-over-year, and down -2304.21% over the past 3 years
- All-Time High Comparison
- NAMS quarterly EBIT is currently -43081.68% below its historical high of -$127.70K set on
- 3-Year Low Comparison
- NAMS quarterly EBIT is +20.00% above its 3-year low of -$68.93M reached on
- Sector Comparison
- NAMS quarterly EBIT is higher than 7.49% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$55.14M | -54.7% | -126.3% | -2304.2% | -10000.0% | |
| Annual EBIT | -$241.60M | – | -36.6% | -483.9% | -3534.2% | |
| TTM EBIT | -$202.93M | -17.9% | -54.3% | -3891.9% | -10000.0% | |
| Price | $35.81 | +8.5% | +40.1% | +211.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $348.00K | -98.2% | -98.8% | +100.0% | +100.0% | |
| Quarterly EPS | -$0.61 | -313.0% | -244.4% | -124.7% | -10000.0% | |
| Quarterly EBITDA | -$55.08M | -54.8% | -126.3% | -2301.4% | -10000.0% | |
| Quarterly Net Income | -$72.01M | -314.7% | -332.5% | -1406.3% | -10000.0% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$35.64M | -54.7% | |
| 3Y | -$2.29M | N/A | -2304.2% |
| 5Y | -$127.70K | N/A | >-9999.0% |
| All | -$127.70K | >-9999.0% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$68.93M | +20.0% | |
| 3Y | -$68.93M | +20.0% | |
| 5Y | -$68.93M | +20.0% | |
| All | -$68.93M | +20.0% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of NAMS?
As of today, NAMS quarterly EBIT is -$55.14M
What is NAMS quarterly EBIT most recent change?
NAMS quarterly EBIT was down -54.74% on September 30, 2025
What is 1-year change in NAMS quarterly EBIT?
NAMS quarterly EBIT is down -126.33% year-over-year
How far is NAMS quarterly EBIT from its all-time high?
NAMS quarterly EBIT is currently -43081.68% below its historical high of -$127.70K set on December 1, 2020
How does NAMS quarterly EBIT rank versus sector peers?
NAMS quarterly EBIT is higher than 7.49% of companies in Healthcare sector
When is NAMS next earnings release?
The next earnings release for NAMS is on
TTM EBIT
-$202.93M$30.78M-17.88%
Summary
- Current Value
- As of today, NAMS TTM EBIT is -$202.93M, down -17.88% on
- Historical Performance
- NAMS TTM EBIT is down -54.29% year-over-year, and down -3891.90% over the past 3 years
- All-Time High Comparison
- NAMS TTM EBIT is currently -158813.08% below its historical high of -$127.70K set on
- 3-Year Low Comparison
- NAMS TTM EBIT is at its 3-year low
- Sector Comparison
- NAMS TTM EBIT is higher than 8.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$202.93M | -17.9% | -54.3% | -3891.9% | -10000.0% | |
| Annual EBIT | -$241.60M | – | -36.6% | -483.9% | -3534.2% | |
| Quarterly EBIT | -$55.14M | -54.7% | -126.3% | -2304.2% | -10000.0% | |
| Price | $35.81 | +8.5% | +40.1% | +211.1% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $35.24M | -44.9% | +7.5% | +100.0% | +100.0% | |
| TTM EPS | -$2.04 | -26.6% | -23.9% | -896.1% | -10000.0% | |
| TTM EBITDA | -$202.72M | -17.9% | -54.2% | -3887.7% | -10000.0% | |
| TTM Net Income | -$221.07M | -33.4% | -48.0% | -5975.3% | -10000.0% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$172.15M | -17.9% | |
| 3Y | -$5.08M | N/A | -3891.9% |
| 5Y | -$127.70K | N/A | >-9999.0% |
| All | -$127.70K | >-9999.0% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$202.93M | at low | |
| 3Y | -$202.93M | at low | |
| 5Y | -$202.93M | at low | |
| All | -$202.93M | at low |
TTM EBIT History
FAQ
What is the current TTM EBIT of NAMS?
As of today, NAMS TTM EBIT is -$202.93M
What is NAMS TTM EBIT most recent change?
NAMS TTM EBIT was down -17.88% on September 30, 2025
What is 1-year change in NAMS TTM EBIT?
NAMS TTM EBIT is down -54.29% year-over-year
How far is NAMS TTM EBIT from its all-time high?
NAMS TTM EBIT is currently -158813.08% below its historical high of -$127.70K set on December 1, 2020
How does NAMS TTM EBIT rank versus sector peers?
NAMS TTM EBIT is higher than 8.21% of companies in Healthcare sector
When is NAMS next earnings release?
The next earnings release for NAMS is on
EBIT Formula
EBIT = − −
Data Sources & References
- NAMS Official Website www.newamsterdampharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1936258/000119312525265796/0001193125-25-265796-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1936258/000095017025027339/0000950170-25-027339-index.htm
- NAMS Profile on Yahoo Finance finance.yahoo.com/quote/NAMS
- NAMS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nams